March 25, 2026 · Form 4 insider transaction
Kihara James bought 2,142 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.